These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 17292867)

  • 1. Development of immunostimulatory virotherapy using non-transmissible Sendai virus-activated dendritic cells.
    Yoneyama Y; Ueda Y; Akutsu Y; Matsunaga A; Shimada H; Kato T; Kubota-Akizawa M; Okano S; Shibata S; Sueishi K; Hasegawa M; Ochiai T; Yonemitsu Y
    Biochem Biophys Res Commun; 2007 Mar; 355(1):129-35. PubMed ID: 17292867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sustained and NK/CD4+ T cell-dependent efficient prevention of lung metastasis induced by dendritic cells harboring recombinant Sendai virus.
    Komaru A; Ueda Y; Furuya A; Tanaka S; Yoshida K; Kato T; Kinoh H; Harada Y; Suzuki H; Inoue M; Hasegawa M; Ichikawa T; Yonemitsu Y
    J Immunol; 2009 Oct; 183(7):4211-9. PubMed ID: 19734206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sendai virus for cancer immunotherapy.
    Ueda Y; Hasegawa M; Yonemitsu Y
    Methods Mol Biol; 2009; 515():299-308. PubMed ID: 19378123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of efficient antitumor immunity using dendritic cells activated by recombinant Sendai virus and its modulation by exogenous IFN-beta gene.
    Shibata S; Okano S; Yonemitsu Y; Onimaru M; Sata S; Nagata-Takeshita H; Inoue M; Zhu T; Hasegawa M; Moroi Y; Furue M; Sueishi K
    J Immunol; 2006 Sep; 177(6):3564-76. PubMed ID: 16951315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complete elimination of established neuroblastoma by synergistic action of gamma-irradiation and DCs treated with rSeV expressing interferon-beta gene.
    Tatsuta K; Tanaka S; Tajiri T; Shibata S; Komaru A; Ueda Y; Inoue M; Hasegawa M; Suita S; Sueishi K; Taguchi T; Yonemitsu Y
    Gene Ther; 2009 Feb; 16(2):240-51. PubMed ID: 18987675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison between Sendai virus and adenovirus vectors to transduce HIV-1 genes into human dendritic cells.
    Hosoya N; Miura T; Kawana-Tachikawa A; Koibuchi T; Shioda T; Odawara T; Nakamura T; Kitamura Y; Kano M; Kato A; Hasegawa M; Nagai Y; Iwamoto A
    J Med Virol; 2008 Mar; 80(3):373-82. PubMed ID: 18205221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant Sendai virus vectors deleted in both the matrix and the fusion genes: efficient gene transfer with preferable properties.
    Inoue M; Tokusumi Y; Ban H; Shirakura M; Kanaya T; Yoshizaki M; Hironaka T; Nagai Y; Iida A; Hasegawa M
    J Gene Med; 2004 Oct; 6(10):1069-81. PubMed ID: 15386740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccinations with dendritic cells primed with apoptotic tumor cells can elicit preventive antitumor immunity in a poorly immunogenic animal model of squamous cell carcinoma.
    Jeong HS; Lee H; Ko Y; Son YI
    Laryngoscope; 2007 Sep; 117(9):1588-93. PubMed ID: 17597627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bacteriophages support anti-tumor response initiated by DC-based vaccine against murine transplantable colon carcinoma.
    Pajtasz-Piasecka E; Rossowska J; Duś D; Weber-Dabrowska B; Zabłocka A; Górski A
    Immunol Lett; 2008 Feb; 116(1):24-32. PubMed ID: 18166233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RIG-I helicase-independent pathway in sendai virus-activated dendritic cells is critical for preventing lung metastasis of AT6.3 prostate cancer.
    Kato T; Ueda Y; Kinoh H; Yoneyama Y; Matsunaga A; Komaru A; Harada Y; Suzuki H; Komiya A; Shibata S; Hasegawa M; Hayashi H; Ichikawa T; Yonemitsu Y
    Neoplasia; 2010 Nov; 12(11):906-14. PubMed ID: 21076616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunostimulatory virotherapy using recombinant Sendai virus as a new cancer therapeutic regimen.
    Yonemitsu Y; Ueda Y; Kinoh H; Hasegawa M
    Front Biosci; 2008 May; 13():4953-9. PubMed ID: 18508560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunity to squamous carcinoma in mice immunized with dendritic cells transfected with genomic DNA from squamous carcinoma cells.
    O-Sullivan I; Ng LK; Martinez DM; Kim TS; Chopra A; Cohen EP
    Cancer Gene Ther; 2005 Oct; 12(10):825-34. PubMed ID: 15891775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunotherapy of established murine squamous cell carcinoma using fused dendritic-tumor cell hybrids.
    Lee WT; Tamai H; Cohen P; Teker AM; Shu S
    Arch Otolaryngol Head Neck Surg; 2008 Jun; 134(6):608-13. PubMed ID: 18559727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination of direct intratumoral administration of dendritic cells and irradiation induces strong systemic antitumor effect mediated by GRP94/gp96 against squamous cell carcinoma in mice.
    Akutsu Y; Matsubara H; Urashima T; Komatsu A; Sakata H; Nishimori T; Yoneyama Y; Hoshino I; Murakami K; Usui A; Kano M; Ochiai T
    Int J Oncol; 2007 Sep; 31(3):509-15. PubMed ID: 17671676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Naked Sendai virus vector lacking all of the envelope-related genes: reduced cytopathogenicity and immunogenicity.
    Yoshizaki M; Hironaka T; Iwasaki H; Ban H; Tokusumi Y; Iida A; Nagai Y; Hasegawa M; Inoue M
    J Gene Med; 2006 Sep; 8(9):1151-9. PubMed ID: 16841365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficient protective immunity against Trypanosoma cruzi infection after nasal vaccination with recombinant Sendai virus vector expressing amastigote surface protein-2.
    Duan X; Yonemitsu Y; Chou B; Yoshida K; Tanaka S; Hasegawa M; Tetsutani K; Ishida H; Himeno K; Hisaeda H
    Vaccine; 2009 Oct; 27(44):6154-9. PubMed ID: 19712768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Newly-developed Sendai virus vector for retinal gene transfer: reduction of innate immune response via deletion of all envelope-related genes.
    Murakami Y; Ikeda Y; Yonemitsu Y; Tanaka S; Kondo H; Okano S; Kohno R; Miyazaki M; Inoue M; Hasegawa M; Ishibashi T; Sueishi K
    J Gene Med; 2008 Feb; 10(2):165-76. PubMed ID: 18074401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-transmissible Sendai virus vector encoding c-myc suppressor FBP-interacting repressor for cancer therapy.
    Matsushita K; Shimada H; Ueda Y; Inoue M; Hasegawa M; Tomonaga T; Matsubara H; Nomura F
    World J Gastroenterol; 2014 Apr; 20(15):4316-28. PubMed ID: 24764668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo vaccination with tumor cell lysate plus CpG oligodeoxynucleotides eradicates murine glioblastoma.
    Wu A; Oh S; Gharagozlou S; Vedi RN; Ericson K; Low WC; Chen W; Ohlfest JR
    J Immunother; 2007; 30(8):789-97. PubMed ID: 18049330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sendai virus for gene therapy and vaccination.
    Griesenbach U; Inoue M; Hasegawa M; Alton EW
    Curr Opin Mol Ther; 2005 Aug; 7(4):346-52. PubMed ID: 16121700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.